Company Filing History:
Years Active: 2011-2014
Title: Innovations of Norman B Purvis
Introduction
Norman B Purvis is a notable inventor based in Brentwood, TN (US). He has made significant contributions to the field of drug-target binding assays, holding a total of three patents. His work has advanced the understanding of drug interactions at the cellular level.
Latest Patents
Purvis's latest patents include innovative methods for analyzing drug-target interactions. One of his patents focuses on a simultaneous assay of target and target-drug binding using differentially labeled antibodies and flow cytometry. This method allows for the first antibody to bind to the total target while the second antibody binds to the drug binding site of the target. The competitive inhibition of the second antibody by drug binding enables a detailed kinetic assessment of drug activity. Another patent similarly addresses the analysis of free drug in samples, utilizing the same principles to provide comprehensive insights into drug-target interactions.
Career Highlights
Norman B Purvis is currently employed at Laboratory Corporation of America Holdings, where he continues to innovate in the field of drug analysis. His work has been instrumental in developing assays that allow for whole cell analysis and the examination of mixed populations of cells.
Collaborations
Purvis collaborates with Gregory T Stelzer, contributing to advancements in their shared field of research.
Conclusion
Norman B Purvis's contributions to drug-target binding assays exemplify the impact of innovative thinking in the medical and scientific communities. His patents reflect a commitment to enhancing drug analysis methodologies, ultimately benefiting research and patient care.